Boris Zaïtra (pictured), currently head of group business development, will be appointed as head of corporate business development, effective 1 july 2024. James Sabry, head of Roche Pharma Partnering, will be retiring after fourteen years in
Boris Zaïtra (pictured), currently head of group business development, will be appointed as head of corporate business development, effective 1 july 2024. James Sabry, head of Roche Pharma Partnering, will be retiring after fourteen years in